Homegrown drugmaker, PE firm among suitors for Samara Capital’s pharma platform

Premium

Samara Capital’s pharma platform has received interest from the country’s top drug maker and a homegrown private equity firm, among other suitors, two people familiar with the development told VCCircle. Samara had mandated an investment banker earlier this year to scout buyers.   Sun Pharma and ChrysCapital have expressed interest in ......